UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042797
Receipt number R000048612
Scientific Title Effect of GLP1 receptor agonist on gastric emptying rate in type 2 DM
Date of disclosure of the study information 2020/12/20
Last modified on 2020/12/20 17:06:52

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of GLP1 receptor agonist on gastric emptying rate in type 2 DM

Acronym

Effect of GLP1 receptor agonist on gastric emptying rate in type 2 DM

Scientific Title

Effect of GLP1 receptor agonist on gastric emptying rate in type 2 DM

Scientific Title:Acronym

Effect of GLP1 receptor agonist on gastric emptying rate in type 2 DM

Region

Japan


Condition

Condition

type2 DM

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the differences in the effects of GLP-1 receptor agonists weight loss and gastric emptying rate.

Basic objectives2

Others

Basic objectives -Others

GLP-1 receptor agonists are known to have a weight loss effect. And the effects of various drugs against weight loss are different, but the mecahnism is not fully understood.
This study was designed considering that the different effects on gastric emptying may be related to the weight loss effect. Various GLP-1 receptor agonists are administered, and after 12 weeks, changes in body weight and gastric emptying rate are examined, and their relationships are investigated.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Changes in glucose, insulin, and gastric emptying rate after administration of GLP-1RA for 12 weeks

Key secondary outcomes

Changes in glucose, insulin, and gastric emptying rate after administration of GLP-1RA for 12 weeks


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

Japanese individuals with type 2 diabetes, untreated or receiving biguanides or sulfonylureas. Inclusion criteria were as follows: Age 40-75 years, HbA1c 12.0% or less, and BMI 40 kg/m2 or less.

Key exclusion criteria

Subjects with type 1 diabetes, severe diabetic autonomic neuropathy, gastrointestinal tract disease including gastroparesis, history of gastrointestinal operation, cardiac disease, pulmonary disease, pancreatic disease, thyroid disease, liver disease, renal disease, alcohol or drug abuse, anti-diabetes drugs other than biguanides or sulfonylureas, diabetogenic medication, malignancy, or pregnancy.

Target sample size

15


Research contact person

Name of lead principal investigator

1st name Kuwata
Middle name
Last name Hitoshi

Organization

Kansai Electric Power Medical Research Institute

Division name

Division of Translational Diabetology

Zip code

553-0003

Address

2-1-7 Fukushima-ku, Osaka 553-0003, Japan

TEL

+81-6-6458-5821

Email

kuwata-kob@umin.ac.jp


Public contact

Name of contact person

1st name kuwata
Middle name
Last name Hitoshi

Organization

Kansai Electric Power Medical Research Institute

Division name

Division of Translational Diabetology

Zip code

553-0003

Address

2-1-7 Fukushima-ku, Osaka 553-0003, Japan

TEL

06-6458-5821

Homepage URL


Email

kuwata-kob@umin.ac.jp


Sponsor or person

Institute

Kansai Electric Power medical Intitute

Institute

Department

Personal name



Funding Source

Organization

self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kansai Electric Power Hospital

Address

2-1-7 Fukushima-ku, Osaka 553-0003, Japan

Tel

+81-6-6458-5821

Email

kuwata-kob@umin.ac.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

25-34

Org. issuing International ID_1

Kansai Electric Power Hospital

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 12 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

15

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2013 Year 06 Month 01 Day

Date of IRB

2013 Year 08 Month 28 Day

Anticipated trial start date

2013 Year 09 Month 01 Day

Last follow-up date

2020 Year 08 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Participants were subjected to meal tolerance tests in the morning after overnight fast after 0wks, 2wks and 12wks GLP-1RA adminsitration.
Bodyweight, glucose, lipid profile and hormons, including total GIP, Glucagon and Insulin, were measured. Gastric emptying rate was determined by mathematical modeling based on changes of 13CO2/12CO2 ratio in breath samples measured by an infrared spectral analyzer .


Management information

Registered date

2020 Year 12 Month 20 Day

Last modified on

2020 Year 12 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048612


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name